News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McBride John S.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/02/2023 |
4
| McBride John S. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| McBride John S. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.97, valued at
$79.4k
|
|
| 09/15/2020 |
4
| McBride John S. (Director) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 1,167 options to buy
@ $500, valued at
$583.6k
|
|
| 07/15/2019 |
4
| McBride John S. (Director) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.88, valued at
$17.6k
|
|
| 06/14/2018 |
4
| McBride John S. (Director) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 9,100 options to buy
@ $6.18, valued at
$56.2k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|